170 related articles for article (PubMed ID: 8534764)
21. Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome.
Egan-Sherry D; Bhuta R; Cole PD; Gennarini LM; Kahn JM; Sulis ML; DeNardo BD; Welch JJG
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e997-e999. PubMed ID: 34001785
[TBL] [Abstract][Full Text] [Related]
22. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies.
Dudeja S; Gupta S; Sharma S; Jain A; Sharma S; Jain P; Aneja S; Chandra J
Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565
[TBL] [Abstract][Full Text] [Related]
23. Vincristine-itraconazole interaction: cause for increasing concern.
Sathiapalan RK; Al-Nasser A; El-Solh H; Al-Mohsen I; Al-Jumaah S
J Pediatr Hematol Oncol; 2002 Oct; 24(7):591. PubMed ID: 12368705
[No Abstract] [Full Text] [Related]
24. Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Whittle AM; Ali S
Int J Lab Hematol; 2008 Apr; 30(2):173-4. PubMed ID: 18333850
[No Abstract] [Full Text] [Related]
25. Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma.
Bashir H; Motl S; Metzger ML; Howard SC; Kaste S; Krasin MP; Hudson MM
J Pediatr Hematol Oncol; 2006 Jan; 28(1):33-5. PubMed ID: 16394890
[TBL] [Abstract][Full Text] [Related]
26. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
27. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
28. Vincristine induced cranial neuropathy.
Dixit G; Dhingra A; Kaushal D
J Assoc Physicians India; 2012 Mar; 60():56-8. PubMed ID: 22799120
[TBL] [Abstract][Full Text] [Related]
29. Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
Kayilioğlu H; Kocak U; Kan Karaer D; Percin EF; Sal E; Tekkesin F; Isik M; Oner N; Belen FB; Yilmaz Keskin E; Okur A; Albayrak M; Kaya Z; Pinarli FG; Yenicesu I; Karadeniz C; Oguz A; Gursel T
J Pediatr Hematol Oncol; 2017 Aug; 39(6):458-462. PubMed ID: 28697165
[TBL] [Abstract][Full Text] [Related]
30. Treatment of vincristine-induced ileus with metoclopramide: A case report.
Masoumi HT; Hadjibabaie M; Zarif-Yeganeh M; Khajeh B; Ghavamzadeh A
J Oncol Pharm Pract; 2019 Mar; 25(2):507-511. PubMed ID: 29224457
[TBL] [Abstract][Full Text] [Related]
31. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
[TBL] [Abstract][Full Text] [Related]
33. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
34. Vincristine-induced vocal cord paralysis in an infant.
Anghelescu DL; De Armendi AJ; Thompson JW; Sillos EM; Pui CH; Sandlund JT
Paediatr Anaesth; 2002 Feb; 12(2):168-70. PubMed ID: 11882230
[TBL] [Abstract][Full Text] [Related]
35. Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma.
Takahashi N; Kameoka Y; Yamanaka Y; Ubukawa K; Saito K; Fujishima M; Fujishima N; Saito H; Hirokawa M; Scott SA; Sawada K
Intern Med; 2008; 47(7):651-3. PubMed ID: 18379154
[TBL] [Abstract][Full Text] [Related]
36. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
37. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
38. Syndrome of inappropriate antidiuretic hormone secretion from concomitant use of itraconazole and vindesine.
Zhou H; Li L; Zhou Y; Han Y
J Clin Pharm Ther; 2018 Feb; 43(1):137-140. PubMed ID: 28782144
[TBL] [Abstract][Full Text] [Related]
39. Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia.
Bacon LC; Barnett MJ; Abou Mourad YR
Ann Hematol; 2012 Jun; 91(6):971-2. PubMed ID: 21976108
[No Abstract] [Full Text] [Related]
40. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
